Omega-3: Clinical Trials

11 trials of Omega-3, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 2 terminated, 1 unknown. 11 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 311Completed 8, Terminated 2, Unknown 1
Phase 23Completed 3

Follow Omega-3: new trials by email Literature Review of Omega-3 trials Research Report on Omega-3

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effect of Diet on Chronic Inflammation and Related Disorders Following Spinal Cord Injury
Omega-3, Vegetation Protein Powder, InflanNox - Neuropathic Pain, Depression
Phase 3CompletedBrock University202014-09-012015-07-30
Oral Omega-3 for Reduction of Kidney Scar Due to Pyelonephritis in Children
Omega-3 - Acute Pyelonephritis(APN)
Phase 3UnknownShahid Beheshti University602014-07-012014-07-17
Effect of Omega-3 Fatty Acid on Endothelial Function
Omega-3, placebo - Familial Hypercholesterolemia
Phase 3CompletedNordlandssykehuset HF342013-03-012019-05-13
Effects of Omega-3 Fatty Acid Supplementation in Acne Patients
Omega-3, Placebo - Acne
Phase 3TerminatedUniversity of California, Los Angeles312013-01-012019-04-17
Omega-3 Fatty Acids and Insulin Sensitivity
Omega-3, placebo - Insulin Resistance
Phase 3CompletedMayo Clinic312012-12-212017-03-03
Omega-3 Supplements to Reduce Antisocial Behaviour in Young Offenders
Omega-3, Placebo, Treatment as Usual - Antisocial Behavior
Phase 2 / Phase 3CompletedSingapore Prison Service1812011-03-012018-08-13
The Effect Of Omega-3 Fatty Acids on Non-alcoholic Fatty Liver Disease
Omacor, lactose tablet - Non Alcoholic Fatty Liver Disease
Phase 3CompletedUniversity of Edinburgh502010-09-012014-01-23
Effect of Omega-3 Supplementation on Child Behavior Problems
omega-3 - Antisocial, Aggressive
Phase 2 / Phase 3CompletedJoint Child Health Project, Mauritius2002010-03-012013-12-19
Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries
Omega-3, Placebo - Metabolic Diseases, Endocrine System Diseases
Phase 3TerminatedDenver Health and Hospital Authority762009-09-012014-09-29
Multi_center Study to Evaluate the Effect of N-3 Fatty Acids (OMEGA-3) on Arrhythmia Recurrence in Atrial Fibrillation
OMEGA-3, Placebo soybean oil - Atrial Fibrillation
Phase 3CompletedMontreal Heart Institute3372009-03-012022-03-17
Folic Acid and Omega -3 Fatty Acid Supplementation in Depressed Older Adults
folic acid, omega-3, vit B12 - Depression
Phase 2 / Phase 3CompletedProf. RH Belmaker152007-05-012012-11-06

Conditions studied

Antisocial Personality Disorder (2)  ·  Depression (2)  ·  Acne Vulgaris (1)  ·  Aggression (1)  ·  Atrial Fibrillation (1)  ·  Cardiovascular Diseases (1)  ·  Cognitive Dysfunction (1)  ·  Diabetes Mellitus (1)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Heart Diseases (1)  ·  Hyperlipoproteinemia Type II (1)  ·  Hypertension (1)  ·  Inflammation (1)  ·  Insulin Resistance (1)

Sponsors

Brock University (1)  ·  Denver Health and Hospital Authority (1)  ·  Joint Child Health Project, Mauritius (1)  ·  Mayo Clinic (1)  ·  Montreal Heart Institute (1)  ·  Nordlandssykehuset HF (1)  ·  Prof. RH Belmaker (1)  ·  Shahid Beheshti University (1)  ·  Singapore Prison Service (1)  ·  University of California, Los Angeles (1)  ·  University of Edinburgh (1)

Countries

United States (3)  ·  Canada (2)  ·  Iran (1)  ·  Israel (1)  ·  Mauritius (1)  ·  Norway (1)  ·  United Kingdom (1)

Top investigators

Adrian Raine (1)  ·  Alaleh Gheisari (1)  ·  Alex Palatnik, MD (1)  ·  Azadeh Eshraghi, Ph.D (1)  ·  Carlin S Long, MD (1)  ·  Carolyn Goh, MD (1)  ·  Christina N Kim, MD (1)  ·  Cyril Dalais, MSc (1)  ·  Danit R Shahar, RD PhD (1)  ·  David J. Allison, MSc. (1)  ·  David S. Ditor, PhD. (1)  ·  Dr. Anil Nigam, MD (1)  ·  Elham Jafari, Ph.D (1)  ·  Golnaz Vaseghi, Ph.D (1)  ·  Ian Lanza, PhD (1)

Results publications

PMID 25146492, PMID 25277614, PMID 25852206, PMID 26545369, PMID 26631058, PMID 28424185, PMID 34817851, PMID 36999528

NIH funding

2008 (1), 5UL1TR000135 (1), KL2TR000136 (1), T32DK007352 (1), U24DK100469 (1)